Histological and biochemical methods to assess aminoacyl-tRNA synthetase expression in human post-mortem brain tissue

Abstract

Aminoacyl-tRNA synthetases are essential, non-redundant enzymes that catalyze the charging of tRNAs with their cognate amino acids. This reaction is a prerequisite for protein translation in all cells. Mutations in human aminoacyl-tRNA synthetases are often associated with defects of the peripheral and central nervous system and are the underlying cause of many rare diseases including neuropathies and leukodystrophies. A comprehensive understanding of aminoacyl-tRNA synthetase expression domains is key to understanding these disorders and developing novel targeted treatment strategies. Here, we describe histological and biochemical methods to analyze the expression pattern of the aspartyl-tRNA synthetase AspRS in human post-mortem brain tissue. The same methods can readily be applied to other members of the aminoacyl-tRNA synthetase superfamily or, more generally, to other cytosolic proteins in the human brain.

Keywords

Aminoacyl-tRNA synthetase / aspartyl-tRNA synthetase / AspRS / DARS1 / post-mortem brain tissue

References

[1] Abbott JA,Robey-Bond SM.Transfer RNA and human disease.Front Genet2014;5:158 PMCID:PMC4042891

[2] Ognjenović J.Human aminoacyl-tRNA synthetases in diseases of the nervous system.RNA Biol2018;15:623-34 PMCID:PMC6103678

[3] Antonellis A.The role of aminoacyl-tRNA synthetases in genetic diseases.Annu Rev Genomics Hum Genet2008;9:87-107

[4] Taft RJ,Leventer RJ.Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.Am J Hum Genet2013;92:774-80 PMCID:PMC3644624

[5] Wolf NI,Kister I.DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder.Neurology2015;84:226-30 PMCID:PMC4335995

[6] Muthiah A,Klugmann M.The leukodystrophies HBSL and LBSL-correlates and distinctions.Front Cell Neurosci2020;14:626610 PMCID:PMC7870476

[7] Scheper GC,van Andel RJ.Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.Nat Genet2007;39:534-9

[8] Dogan SA,Maiti P.Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart.Cell Metab2014;19:458-69

[9] Fröhlich D,Spencer ZH.In vivo characterization of the aspartyl-tRNA synthetase DARS: homing in on the leukodystrophy HBSL.Neurobiol Dis2017;97:24-35

[10] Fröhlich D,Kueh AJ.A hypomorphic Dars1^D367Y model recapitulates key aspects of the leukodystrophy HBSL.Front Cell Neurosci2020;14:625879 PMCID:PMC7855723

[11] Klugmann M,Delerue F.Developmental delay and late onset HBSL pathology in hypomorphic Dars1^M256L mice.Neurochem Res2022;47:1972-84 PMCID:PMC9217829

[12] Fröhlich D,Voss C.Expression pattern of the aspartyl-tRNA synthetase DARS in the human brain.Front Mol Neurosci2018;11:81 PMCID:PMC5869200

[13] Lipman NS,Trudel LJ.Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources.ILAR J2005;46:258-68

[14] Howat WJ,Jones P.Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers.Methods2014;70:34-8 PMCID:PMC4240800